This page shows the latest enadenotucirev news and features for those working in and with pharma, biotech and healthcare.
That project will look at the safety and efficacy of enadenotucirev - which is made by PsiOxus Therapeutics in Oxford, UK - in combination with Opdivo for the treatment of a range of
BMS to explore new options for its immuno-oncology drug Opdivo. Partners with PsiOxis to research its use with enadenotucirev. ... BMS has then reserved the rights to first pick of any enadenotucirev products developed through the partnership.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...